Literature DB >> 20412341

Pattern of intravesical recurrence after surgical treatment for urothelial cancer of the upper urinary tract: a single institutional retrospective long-term follow-up study.

Ei-Ichiro Takaoka1, Shiro Hinotsu, Akira Joraku, Takehiro Oikawa, Noritoshi Sekido, Naoto Miyanaga, Koji Kawai, Toru Shimazui, Hideyuki Akaza.   

Abstract

OBJECTIVES: To estimate the risk of intravesical recurrence in patients with primary urothelial cancer of the upper urinary tract.
METHODS: Ninety patients who underwent radical nephroureterectomy for clinically localized urothelial cancer of the upper urinary tract were initially considered. Those with a previous and/or concomitant history of bladder cancer, and those who had previously received systemic chemotherapy were excluded. Overall, data from 60 patients with no evidence of bladder cancer and distant or lymph node metastasis were retrospectively reviewed. The clinical course and the risk pattern of intravesical recurrence were estimated by using a smoothing technique on estimated hazard function plots. Multivariate analysis was carried out using a Cox proportional hazards regression model.
RESULTS: Mean patient age was 64.7 years. Median follow up was 51.3 months. Thirty patients (50%) had intravesical recurrence during the follow-up period. The peak of intravesical recurrence was detected in the early period (less than 2.5 years) after surgery. The intravesical recurrence hazard became lower afterwards. Nevertheless, it persisted over a long period of time. On univariate and multivariate analyses, none of the clinical or pathological parameters had a statistically significant impact on intravesical recurrence.
CONCLUSIONS: Even if an intravesical recurrence in patients with upper urinary tract urothelial cancer is more likely in the early period, it persists over a long period of time. This might reflect different mechanisms of recurrence, having a significant impact on the definition of the optimal treatment and follow-up schedules.

Entities:  

Mesh:

Year:  2010        PMID: 20412341     DOI: 10.1111/j.1442-2042.2010.02539.x

Source DB:  PubMed          Journal:  Int J Urol        ISSN: 0919-8172            Impact factor:   3.369


  8 in total

Review 1.  Perioperative chemotherapy for upper tract urothelial cancer.

Authors:  Ajjai S Alva; Surena F Matin; Seth P Lerner; Arlene O Siefker-Radtke
Journal:  Nat Rev Urol       Date:  2012-04-10       Impact factor: 14.432

2.  Predictors of Intravesical Recurrence After Radical Nephroureterectomy and Prognosis in Patients with Upper Tract Urothelial Carcinoma.

Authors:  Yun-Ren Li; Kai-Jie Yu; Ying-Hsu Chang; Po-Hung Lin; I-Hung Shao; Hung-Cheng Kan; Yuan-Cheng Chu; Cheng-Keng Chuang; See-Tong Pang; Chung-Yi Liu
Journal:  Cancer Manag Res       Date:  2020-08-19       Impact factor: 3.989

3.  Assessment of Therapeutic Benefit and Option Strategy on Intravesical Instillation for Preventing Bladder Cancer Recurrence after Radical Nephroureterectomy in Patients with Upper Urinary Tract Urothelial Carcinoma.

Authors:  Bo Fan; Qiliang Teng; Min Sun; Yingzi Wang; Yutong Wang; Zhe Lin; Yuchao Wang; Xu Duan; Liren Zhang; Tingyu Chen; Sishan Chen; Yu Tai; Ce Zhang; Xishuang Song; Zhiyu Liu
Journal:  J Oncol       Date:  2022-05-30       Impact factor: 4.501

4.  The neutrophil-to-lymphocyte ratio as a predictor of intravesical recurrence in patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.

Authors:  Nozomu Kishimoto; Tetsuya Takao; Sohei Kuribayashi; Gaku Yamamichi; Kosuke Nakano; Masataka Kawamura; Koichi Tsutahara; Go Tanigawa; Seiji Yamaguchi
Journal:  Int J Clin Oncol       Date:  2016-09-10       Impact factor: 3.402

Review 5.  Association between demographic factors and prognosis in urothelial carcinoma of the upper urinary tract: a systematic review and meta-analysis.

Authors:  Hyung Suk Kim; Chang Wook Jeong; Cheol Kwak; Hyeon Hoe Kim; Ja Hyeon Ku
Journal:  Oncotarget       Date:  2017-01-31

6.  Predictive Value of Preoperative Positive Urine Cytology for Development of Bladder Cancer After Nephroureterectomy in Patients With Upper Urinary Tract Urothelial Carcinoma: A Prognostic Nomogram Based on a Retrospective Multicenter Cohort Study and Systematic Meta-Analysis.

Authors:  Bo Fan; Yuanbin Huang; Shuang Wen; Qiliang Teng; Xinrui Yang; Man Sun; Tingyu Chen; Yan Huang; Yumei Wang; Zhiyu Liu
Journal:  Front Oncol       Date:  2021-10-01       Impact factor: 6.244

7.  Clinicopathological spectrum and the outcome of treatment of upper tract transitional cell carcinoma.

Authors:  Surdas Radhakrishnan; Pallavi Aga; Manoj Jain; Aneesh Srivastava; Rakesh Kapoor; Anil Mandhani
Journal:  Indian J Urol       Date:  2012-04

8.  Impact of double J stenting or nephrostomy placement during transurethral resection of bladder tumour on the incidence of metachronous upper urinary tract urothelial cancer.

Authors:  Marie C Hupe; Lukas Dormayer; Tomasz Ozimek; Julian P Struck; Martin J P Hennig; Melanie Klee; Christoph A J von Klot; Markus A Kuczyk; Axel S Merseburger; Mario W Kramer
Journal:  BMC Cancer       Date:  2020-02-21       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.